Natixis’s Intuitive Surgical ISRG Stock Holding History

Natixis’s Portfolio ISRG Stock Details ISRG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-22,500	Closed	-$5.97M	–	1087
2022 Q4	$5.97M	Buy	+22,500	New	+$5.49M	0.03%	351

Other funds holding ISRG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Natixis's ISRG Position: Q2 2026 in Review

Natixis reduced its Intuitive Surgical (ISRG) stake by 59% in Q2 2026, selling an estimated $20.8M and leaving 33,071 shares worth $13.2M. The position accounts for 0.05% of the portfolio, ranked #244.

Natixis first reported a position in ISRG in Q2 2013 and has held it in 45 quarters since. The position peaked at $88.6M in Q1 2022. 2,251 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

Natixis held 33,071 shares of Intuitive Surgical worth $13.2M as of Q2 2026.
Natixis sold 47,706 Intuitive Surgical shares in Q2 2026, an estimated $20.8M.
Intuitive Surgical made up 0.05% of Natixis's portfolio in Q2 2026, its #244 holding.
Natixis first reported a position in Intuitive Surgical in Q2 2013 and has held it in 45 quarters since.
Natixis's Intuitive Surgical position peaked at $88.6M in Q1 2022.
2,251 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Natixis's 13F filing for Q2 2026, filed 13 Aug 2026.